Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KITE-753 by Gilead Sciences for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
KITE-753 is under clinical development by Gilead Sciences and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to...